CosLeaguer Global

코스리거글로벌 · 043710

Industrials Trading & Distribution · KOSDAQ

Small-cap

Market cap US$49.4M (₩68.1B)

Overview

CosLeaguer Global distributes medical-aesthetic injectables, such as botulinum toxin (a muscle-relaxing treatment used in cosmetic procedures) and dermal fillers, and also manufactures and distributes skincare and cosmetic products.

Its customers include clinics and consumers seeking medical-beauty and skincare solutions, and it connects Korean-beauty brands with domestic and international influencer-commerce channels. Listed on KOSDAQ, Korea's tech and small-cap board, the company operates across four segments: healthcare distribution, cosmetics manufacturing, eco-friendly appliances, and new-media marketing.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$25.8M

▲ +84.4% YoY

Operating profit · FY2025

−US$6M

Loss widened

Net income · FY2025

−US$6.3M

Turned to loss

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$16.3M(₩22.6B)	US$14M(₩19.3B)	US$25.8M(₩35.7B)
Operating profit	−US$5.5M(−₩7.5B)	−US$2.4M(−₩3.3B)	−US$6M(−₩8.3B)
Net income	N/A(see filing)	US$3.9M(₩5.4B)	−US$6.3M(−₩8.7B)

Revenue

FY2023US$16.3M
FY2024US$14M
FY2025US$25.8M

Operating profit

FY2023−US$5.5M
FY2024−US$2.4M
FY2025−US$6M

Net income

FY2023N/A
FY2024US$3.9M
FY2025−US$6.3M

Key ratios (FY2025)

ROE

-22.3%

Debt/Eq

476.6%

Op. margin

-23.4%

Net margin

-24.5%

Rev. YoY

▲ +84.4%

Why it matters

The company wholly owns a dermacosmetics ODM manufacturing subsidiary, Cosleager, and has acquired Moments Company, operator of the skincare brand 'B'plain', to integrate planning, manufacturing, and distribution in-house.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?